Cat: IPD-X26979

Recombinant Rat Galectin-8/LGALS8 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    Galectin-8/LGALS8

  • 简介

    Galectin-8 belongs to the family of animal lectins that bind to different glycoconjugates. Galectin-8 inhibits MTOR and AMPK signaling pathways to induce autophagy in response to lysosomal damage. Galectin-8 is highly expressed in a variety of tumors. Galectin-8 Protein, Rat (His) is the recombinant rat-derived Galectin-8, expressed by E. coli, with N-6*His labeled tag. The total length of Galectin-8 Protein, Rat (His) is 316 a.a..

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its binding ability in a functional ELISA. Immobilized SLC31A1 at 5 μg/mL (100 μL/well) can bind Rat Galectin-8. The ED50 for this effect is 3.773 μg/mL. Measured by its binding ability in a functional ELISA. Immobilized SLC31A1 at 5 μg/mL (100 μL/well) can bind Rat Galectin-8, The ED50 for this effect is 3.773 μg/mL.

  • Alternative Names

    Galectin-8; Gal-8; Po66 Carbohydrate-Binding Protein; Po66-CBP; Prostate Carcinoma Tumor Antigen 1; PCTA-1; LGALS8

  • Species

    Rat

  • Source

    E. coli

  • Tag

    N-6*His

  • Purity

    Greater than 95% as determined by SDS-PAGE.

  • Uniprot

    Q6IN24

  • Expression Region

    M1-W316

  • AA Sequence

    MLSLSNLQNIIYNPTIPYVSTITEQLKPGSLIVIRGHVPKDSERFQVDFQHGNSLKPRADVAFHFNPRFKRSNCIVCNTLTNEKWGWEEITHDMPFRKEKSFEIVIMVLKNKFQVAVNGKHILLYAHRINPEKIDTLGIYGKVNIHSIGFRFSSDLQSMETSTLGLTQISKENIQKSGKLHLSLPFEARLNASMGPGRTVVVKGEVNTNAKSFNVDLVAGRSRDIALHLNPRLNVKAFVRNSFLQDAWGEEERNITCFPFSSGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKDLSSIDTLAVDGDIRLLDVRSW

  • Protein Length

    Full Length

  • Molecular Weight

    34 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Galectin-8 (LGALS8) is a member of the galectin family, a group of proteins known for their ability to bind beta-galactoside sugars, playing crucial roles in various biological processes, including cell adhesion, proliferation, and apoptosis. The expression of LGALS8 has been implicated in several physiological and pathological conditions, including cancer, inflammation, and autoimmune diseases. Its unique N-terminal and C-terminal domains allow it to interact with multiple partners, influencing cellular signaling pathways. Research has shown that LGALS8 can modulate immune responses and contribute to tumor progression by altering the tumor microenvironment and facilitating metastasis. Consequently, the study of LGALS8 is vital for understanding its functional roles in health and disease. The development of recombinant LGALS8 proteins has provided a valuable tool for investigating these mechanisms in vitro and in vivo, enabling researchers to dissect its biological functions, explore its therapeutic potentials, and evaluate its role as a biomarker for disease progression. As interest in galectins expands, LGALS8 stands out as a significant candidate for further exploration in targeted therapies and diagnostics, highlighting the need for continued research in this promising area of biomedical science.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US